sj-tif-2-tah-10.1177_20406207231201454 – Supplemental material for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

  • Hagop M. Kantarjian (Creator)
  • Aaron C. Logan (Creator)
  • Faraz Zaman (Creator)
  • Nicola Gökbuget (Creator)
  • Ralf C. Bargou (Creator)
  • Yi Zeng (Creator)
  • Gerhard Zugmaier (Creator)
  • Franco Locatelli (Creator)

Dataset

Description

Supplemental material, sj-tif-2-tah-10.1177_20406207231201454 for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab by Hagop M. Kantarjian, Aaron C. Logan, Faraz Zaman, Nicola Gökbuget, Ralf C. Bargou, Yi Zeng, Gerhard Zugmaier and Franco Locatelli in Therapeutic Advances in Hematology
Dati resi disponibili2023
EditoreSAGE Journals

Accesso dataset

Cita questo